Clinical Trials Browser

Completed × NIH × Cystadenocarcinoma, Serous × Clear all

NCT02101788 2025-11-13

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Phase 2/3 Completed

260 enrolled 20 charts

Cystadenocarcinoma, Serous

NCT00551070 2020-12-03

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

Phase 2 Completed

52 enrolled 11 charts

Cystadenocarcinoma, Serous